Abstract:Crimean-Congo Hemorrhagic Fever virus (CCHFV) is a tick-borne pathogen that causes severe acute fever disease in humans and requires a biosafety level 4 laboratory for handling. Hazara virus (HAZV), belonging to the same virus genus as CCHFV, does not exhibit pathogenesis in humans. To investigate host RNA-binding proteins (RBPs) that regulate CCHFV replication, we generated a series of mutant RAW264.7 cells by CRISPR/Cas9 system and these cells were infected with HAZV. The viral titers in the supernatant of these cells was investigated, and HuR (ELAVL1) was identified. HuR KO RAW264.7 cells reduced HAZV replication. HuR is an RBP that enhances mRNA stability by binding to adenyl-uridine (AU)-rich regions in their 3′ non-coding region (NCR). HuR regulates innate immune response by binding to host mRNAs of signaling molecules. The expression of cytokine genes such as Ifnb , Il6 , and Tnf was reduced in HuR KO cells after HAZV infection. Although HuR supports the innate immune response during HAZV infection, we found that innate immune activation by HAZV infection did not affect its replication. We then investigated whether HuR regulates HAZV genome RNA stability. HAZV RNA genome was precipitated with an anti-HuR antibody, and HAZV genome RNA stability was lowered in HuR KO cells. We found that HuR associated with HAZV RNA and stabilized it to enhance HAZV replication. Furthermore, HuR-deficiency reduced CCHFV minigenome replication. CCHFV is a negative-strand RNA virus and positive-strand RNA is produced during replication. HuR was associated with positive-strand RNA rather than negative-strand RNA, and AU-rich region in 3'-NCR of S segment was responsible for immunoprecipitation with anti-HuR antibody and minigenome replication. Additionally, HuR inhibitor treatment reduced CCHFV minigenome replication. Our results indicate that HuR aids replication of the CCHFV minigenome by associating with the AU-rich region in the 3′-NCR. Crimean-Congo Hemorrhagic Fever virus (CCHFV) is a tick-borne pathogen that causes severe acute fever disease in humans and requires a biosafety level 4 laboratory for handling. Hazara virus (HAZV), the same genus of CCHFV, has been used as a model virus to reveal the molecular mechanism of CCHFV infection. To investigate host factors for CCHFV replication, we generated a series of mutant RAW264.7 cells and conducted screening for host genes that regulate the replication of HAZV, identifying HuR (ELAVL1). HuR is an RNA-binding protein (RBP) that enhances mRNA stability by binding to its 3′ non-coding region (NCR). We found that HuR is associated with the CCHFV RNA stability by binding to its 3'-NCR, and the minigenome assay showed that CCHFV replication is supported by HuR. HuR inhibitor treatment also reduced CCHFV minigenome replication. These findings present a possible starting point for the future development of antiviral drug targeting host RBPs. Combination treatment with RdRp and RBP inhibitors may be a potential therapeutic strategy in the future.

A genome-wide CRISPR screen identifies HuR as a regulator of apoptosis induced by dsRNA and virus

HuR controls apoptosis and activation response without effects on cytokine 3’ UTRs

RNA-binding protein HuR inhibition induces multiple programmed cell death in breast and prostate cancer

Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence.

The RNA-binding protein HuR in human cancer: A friend or foe?

Targeting the RNA-binding protein HuR in cancer.

The Role of RNA-Binding Protein HuR in Lung Cancer by RNA Sequencing Analysis

CRISPR/Cas9-Mediated Knockout of the HuR Gene in U251 Cell Inhibits Japanese Encephalitis Virus Replication

pADP-ribosylation regulates the cytoplasmic localization, cleavage, and pro-apoptotic function of HuR

RNA binding protein HuD promotes autophagy and tumor stress survival by suppressing mTORC1 activity and augmenting ARL6IP1 levels

Abstract A043: The tumor-intrinsic RNA binding protein HuR is essential for anti-tumor immunity in PDAC

Abstract 5357: The tumor-intrinsic RNA binding protein HuR is essential for anti-tumor immunity in PDAC

MiR-291b-3p Induces Apoptosis in Liver Cell Line NCTC1469 by Reducing the Level of RNA-binding Protein HuR.

Human antigen R and drug resistance in tumors

RNA-binding Protein HuR Regulates Hsa-Let-7c Expression by Its RNA Recognition Motif.

The RNA-binding protein HuR is a negative regulator in adipogenesis

HuR (ELAVL1) regulates the CCHFV minigenome and HAZV replication by associating with viral genomic RNA

The Role of Human Antigen R (hur) in Modulating Proliferation, Senescence and Radiosensitivity of Skin Cells

Multiple Functions of HuR in Urinary Tumors

The RNA-binding Protein HuR Regulates Intestinal Epithelial Restitution by Modulating Caveolin-1 Gene Expression